[{"symbol": "DTSS", "publishedDate": "2026-01-19 02:26:47", "publisher": "Defense World", "title": "Head-To-Head Contrast: Datasea (NASDAQ:DTSS) vs. SoundHound AI (NASDAQ:SOUN)", "image": "https://images.financialmodelingprep.com/news/headtohead-contrast-datasea-nasdaqdtss-vs-soundhound-ai-nasdaqsoun-20260119.png", "site": "defenseworld.net", "text": "SoundHound AI (NASDAQ: SOUN - Get Free Report) and Datasea (NASDAQ: DTSS - Get Free Report) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, risk and dividends. Insider and Institutional Ownership 19.3% of SoundHound", "url": "https://www.defenseworld.net/2026/01/19/head-to-head-contrast-datasea-nasdaqdtss-vs-soundhound-ai-nasdaqsoun.html"}, {"symbol": "RPID", "publishedDate": "2026-01-15 18:15:57", "publisher": "Seeking Alpha", "title": "Rapid Micro Biosystems, Inc. (RPID) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript", "image": "https://images.financialmodelingprep.com/news/rapid-micro-biosystems-inc-rpid-presents-at-44th-annual-20260115.jpg", "site": "seekingalpha.com", "text": "Rapid Micro Biosystems, Inc. (RPID) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript", "url": "https://seekingalpha.com/article/4860302-rapid-micro-biosystems-inc-rpid-presents-at-44th-annual-j-p-morgan-healthcare-conference"}, {"symbol": "IRE", "publishedDate": "2026-01-15 07:00:00", "publisher": "Seeking Alpha", "title": "IRE: IREN's Growth Outlook May Provide For An Appealing Trade Strategy", "image": "https://images.financialmodelingprep.com/news/ire-irens-growth-outlook-may-provide-for-an-appealing-20260115.jpg", "site": "seekingalpha.com", "text": "The Defiance Daily Target 2X Long IREN ETF offers 2x daily exposure to IREN Limited and is best suited for short-term trading. IRE stands out for its exceptional liquidity, with $270mm in net assets and a $120.46mm average daily trading volume, supporting efficient execution. IREN is a high-growth, profitable data center operator with major expansion plans and trades at an attractive 23.15x GAAP P/E.", "url": "https://seekingalpha.com/article/4860028-ire-irens-growth-outlook-may-provide-for-an-appealing-trade-strategy"}, {"symbol": "RPID", "publishedDate": "2026-01-13 16:15:00", "publisher": "GlobeNewsWire", "title": "Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue", "image": "https://images.financialmodelingprep.com/news/rapid-micro-biosystems-announces-record-preliminary-unaudited-fourth-quarter-20260113.jpg", "site": "globenewswire.com", "text": "LEXINGTON, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the \u201cCompany\u201d), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced preliminary unaudited fourth quarter and full year 2025 revenue.", "url": "https://www.globenewswire.com/news-release/2026/01/13/3218262/33206/en/Rapid-Micro-Biosystems-Announces-Record-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2025-Revenue.html"}, {"symbol": "SMCX", "publishedDate": "2026-01-13 12:58:00", "publisher": "Benzinga", "title": "What's Going On With Super Micro Computer Stock Today?", "image": "https://images.financialmodelingprep.com/news/whats-going-on-with-super-micro-computer-stock-today-20260113.jpeg", "site": "feeds.benzinga.com", "text": "Super Micro Computer, Inc. (NASDAQ: SMCI) shares are tumbling Tuesday. The decline comes amid negative analyst coverage from Goldman Sachs.", "url": "https://www.benzinga.com/trading-ideas/movers/26/01/49885148/whats-going-on-with-super-micro-computer-stock-today"}, {"symbol": "VELO", "publishedDate": "2026-01-13 09:00:00", "publisher": "PRNewsWire", "title": "Velo3D Partners with U.S. Army for 3D Printing Solutions", "image": "https://images.financialmodelingprep.com/news/velo3d-partners-with-us-army-for-3d-printing-solutions-20260113.jpg", "site": "prnewswire.com", "text": "FREMONT, Calif., Jan. 13, 2026 /PRNewswire/ -- Velo3D, Inc. (NASDAQ: VELO), a leading additive manufacturing technology company for mission-critical metal parts has entered into a Cooperative Research & Development Agreement (CRADA) with the U.S. Army DEVCOM Ground Vehicle Systems Center (GVSC) to rapidly develop and qualify additively manufactured complex parts and assemblies, addressing critical supply chain challenges affecting ground combat vehicles and other military systems.", "url": "https://www.prnewswire.com/news-releases/velo3d-partners-with-us-army-for-3d-printing-solutions-302656905.html"}, {"symbol": "QNCX", "publishedDate": "2026-01-12 11:08:28", "publisher": "Seeking Alpha", "title": "Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential", "image": "https://images.financialmodelingprep.com/news/quince-therapeutics-good-potential-in-orphan-disease-in-q1-20260112.jpg", "site": "seekingalpha.com", "text": "Quince Therapeutics is rated Buy ahead of its pivotal Phase 3 NEAT trial readout in Ataxia-Telangiectasia (A-T) expected mid-Q1 2026. eDSP, QNCX's lead asset, offers chronic corticosteroid delivery with reduced toxicity, targeting a $1B+ orphan market with no approved therapies. The NEAT trial addresses prior design flaws, is 90% powered for statistical significance in 6-9 year-olds, and enjoys strong regulatory alignment.", "url": "https://seekingalpha.com/article/4858790-quince-therapeutics-good-potential-in-orphan-disease-in-q1-with-platform-potential"}, {"symbol": "DTSS", "publishedDate": "2026-01-12 09:30:00", "publisher": "PRNewsWire", "title": "Datasea Announces Major Acoustic Technology Advancements in Brain-Computer Interface Applications", "image": "https://images.financialmodelingprep.com/news/datasea-announces-major-acoustic-technology-advancements-in-braincomputer-interface-20260112.jpg", "site": "prnewswire.com", "text": "Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain\u2013Computer Interface Market BEIJING, Jan. 12, 2026 /PRNewswire/ --\u00a0Datasea Inc. (NASDAQ: DTSS) (\"Datasea\" or the \"Company\"), a technology company specializing in acoustic high-tech innovation and AI-powered multimodal systems, today announced that its China-based operating entities and subsidiaries have recently made progress in two acoustic-driven technology initiatives related to brain\u2013computer interfaces (\"BCI\") and rehabilitation robot control, leveraging proprietary acoustic-driven technologies. The Company stated that these advancements represent an important extension of its acoustic-driven BCI core technology framework previously disclosed in late 2025.", "url": "https://www.prnewswire.com/news-releases/datasea-announces-major-acoustic-technology-advancements-in-braincomputer-interface-applications-302658370.html"}, {"symbol": "DTSS", "publishedDate": "2026-01-12 02:10:52", "publisher": "Defense World", "title": "Baozun (NASDAQ:BZUN) versus Datasea (NASDAQ:DTSS) Critical Review", "image": "https://images.financialmodelingprep.com/news/baozun-nasdaqbzun-versus-datasea-nasdaqdtss-critical-review-20260112.png", "site": "defenseworld.net", "text": "Baozun (NASDAQ: BZUN - Get Free Report) and Datasea (NASDAQ: DTSS - Get Free Report) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership. Profitability This table compares Baozun and Datasea's", "url": "https://www.defenseworld.net/2026/01/12/baozun-nasdaqbzun-versus-datasea-nasdaqdtss-critical-review.html"}, {"symbol": "QNCX", "publishedDate": "2026-01-12 01:50:50", "publisher": "Defense World", "title": "Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives Consensus Rating of \u201cModerate Buy\u201d from Brokerages", "image": "https://images.financialmodelingprep.com/news/quince-therapeutics-inc-nasdaqqncx-receives-consensus-rating-of-moderate-20260112.png", "site": "defenseworld.net", "text": "Quince Therapeutics, Inc. (NASDAQ: QNCX - Get Free Report) has received a consensus rating of \"Moderate Buy\" from the seven analysts that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, four have assigned a buy recommendation and one has assigned a strong", "url": "https://www.defenseworld.net/2026/01/12/quince-therapeutics-inc-nasdaqqncx-receives-consensus-rating-of-moderate-buy-from-brokerages.html"}, {"symbol": "SOWG", "publishedDate": "2026-01-08 12:19:24", "publisher": "CNBC", "title": "ICE shooting: State officials say FBI is blocking evidence in Minneapolis investigation", "image": "https://images.financialmodelingprep.com/news/ice-shooting-state-officials-say-fbi-is-blocking-evidence-20260108.jpg", "site": "cnbc.com", "text": "A Minnesota law enforcement agency said that the FBI has blocked it from examining evidence in the fatal shooting of Renee Nicole Good by a U.S. Immigration and Customs Enforcement agent in Minneapolis. The Minnesota Bureau of Criminal Apprehension said that the FBI's current stance was a reversal of an initial agreement that the BCA would conduct a joint investigation of Good's killing with the FBI.", "url": "https://www.cnbc.com/2026/01/08/ice-shooting-renee-nicole-good-fbi-evidence.html"}, {"symbol": "RPID", "publishedDate": "2026-01-07 09:00:00", "publisher": "GlobeNewsWire", "title": "Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/rapid-micro-biosystems-to-present-at-44th-annual-jp-20260107.jpg", "site": "globenewswire.com", "text": "LEXINGTON, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the \u201cCompany\u201d), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 44th Annual J.P.", "url": "https://www.globenewswire.com/news-release/2026/01/07/3214560/33206/en/Rapid-Micro-Biosystems-to-Present-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html"}, {"symbol": "VELO", "publishedDate": "2026-01-05 12:41:08", "publisher": "Benzinga", "title": "Momentus Stock Rockets After 3D-Printed Fuel Tank Preps For Space Test", "image": "https://images.financialmodelingprep.com/news/momentus-stock-rockets-after-3dprinted-fuel-tank-preps-for-20260105.jpeg", "site": "feeds.benzinga.com", "text": "Momentus Inc. rose after announcing 3D-printed fuel tank for space testing on Vigoride-7, showcasing potential for cost and time savings.", "url": "https://www.benzinga.com/trading-ideas/movers/26/01/49701298/momentus-stock-rockets-after-3d-printed-fuel-tank-preps-for-space-test"}, {"symbol": "DTSS", "publishedDate": "2026-01-05 10:04:00", "publisher": "PRNewsWire", "title": "Datasea Announces Strategic Collaboration with a Leading Brain-Computer Interface Company in China", "image": "https://images.financialmodelingprep.com/news/datasea-announces-strategic-collaboration-with-a-leading-braincomputer-interface-20260105.jpg", "site": "prnewswire.com", "text": "Acoustic Enhancement Technology Expands into the Multi-Billion-Dollar Non-Invasive BCI and Healthcare Applications Market BEIJING, Jan. 5, 2026 /PRNewswire/ -- Datasea Inc. (the \"Company\" or \"Datasea\") today announced that its China operating subsidiary, Datasea Jingwei Information Technology Co., Ltd., has entered into a strategic collaboration agreement with Nanjing Linghang Intelligent Aviation Technology Co., Ltd.", "url": "https://www.prnewswire.com/news-releases/datasea-announces-strategic-collaboration-with-a-leading-braincomputer-interface-company-in-china-302652750.html"}, {"symbol": "SOWG", "publishedDate": "2026-01-05 07:22:44", "publisher": "Defense World", "title": "Maison Solutions (NASDAQ:MSS) and Sow Good (NASDAQ:SOWG) Critical Analysis", "image": "https://images.financialmodelingprep.com/news/maison-solutions-nasdaqmss-and-sow-good-nasdaqsowg-critical-analysis-20260105.jpg", "site": "defenseworld.net", "text": "Maison Solutions (NASDAQ: MSS - Get Free Report) and Sow Good (NASDAQ: SOWG - Get Free Report) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk. Analyst Recommendations This is a breakdown", "url": "https://www.defenseworld.net/2026/01/05/maison-solutions-nasdaqmss-and-sow-good-nasdaqsowg-critical-analysis.html"}, {"symbol": "RPID", "publishedDate": "2025-12-30 01:46:43", "publisher": "Defense World", "title": "Reviewing Advanced Biomedical Technologies (OTCMKTS:ABMT) and Rapid Micro Biosystems (NASDAQ:RPID)", "image": "https://images.financialmodelingprep.com/news/reviewing-advanced-biomedical-technologies-otcmktsabmt-and-rapid-micro-biosystems-20251230.png", "site": "defenseworld.net", "text": "Advanced Biomedical Technologies (OTCMKTS:ABMT - Get Free Report) and Rapid Micro Biosystems (NASDAQ: RPID - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings. Profitability This table compares Advanced Biomedical", "url": "https://www.defenseworld.net/2025/12/30/reviewing-advanced-biomedical-technologies-otcmktsabmt-and-rapid-micro-biosystems-nasdaqrpid.html"}, {"symbol": "SOWG", "publishedDate": "2025-12-27 02:07:15", "publisher": "Defense World", "title": "Sow Good (OTCMKTS:SOWG)  Shares Down 1.4%   \u2013 What\u2019s Next?", "image": "https://images.financialmodelingprep.com/news/sow-good-otcmktssowg-shares-down-14-whats-next-20251227.png", "site": "defenseworld.net", "text": "Sow Good Inc. (OTCMKTS:SOWG - Get Free Report)'s share price traded down 1.4% during mid-day trading on Friday. The company traded as low as $0.44 and last traded at $0.4535. 66,766 shares were traded during trading, a decline of 89% from the average session volume of 587,136 shares. The stock had previously closed at", "url": "https://www.defenseworld.net/2025/12/27/sow-good-otcmktssowg-shares-down-1-4-whats-next.html"}, {"symbol": "VELO", "publishedDate": "2025-12-22 09:02:51", "publisher": "Benzinga", "title": "Velo3D Wins $32.6 Million Defense Contract, Stock Soars", "image": "https://images.financialmodelingprep.com/news/velo3d-wins-326-million-defense-contract-stock-soars-20251222.jpeg", "site": "feeds.benzinga.com", "text": "Velo3D, Inc. (VELO) stock surges on $32.6M defense contract to eliminate production bottlenecks and increase output of complex components.", "url": "https://www.benzinga.com/trading-ideas/movers/25/12/49535961/velo3d-wins-32-6-million-defense-contract-stock-soars"}, {"symbol": "VELO", "publishedDate": "2025-12-22 08:15:00", "publisher": "PRNewsWire", "title": "Velo3D Announces $30 Million Private Placement of Common Stock", "image": "https://images.financialmodelingprep.com/news/velo3d-announces-30-million-private-placement-of-common-stock-20251222.jpg", "site": "prnewswire.com", "text": "The offering is led by a $20 million investment from a new fundamental institutional investor with additional participation from a large existing institutional shareholder FREMONT, Calif. , Dec. 22, 2025 /PRNewswire/ -- Velo3D, Inc. (NASDAQ: VELO), a leading additive manufacturing technology company for mission-critical metal parts (the \"Company\"), today announced that it has entered into a securities purchase agreement with two fundamental institutional investors to raise $30 million of gross proceeds via a private investment in public equity (\"PIPE\") transaction.", "url": "https://www.prnewswire.com/news-releases/velo3d-announces-30-million-private-placement-of-common-stock-302647773.html"}, {"symbol": "VELO", "publishedDate": "2025-12-22 07:00:00", "publisher": "PRNewsWire", "title": "Velo3D Secures Department of War Contract Valued at $32.6M to Eliminate Critical Defense Manufacturing Bottleneck", "image": "https://images.financialmodelingprep.com/news/velo3d-secures-department-of-war-contract-valued-at-326m-20251222.jpg", "site": "prnewswire.com", "text": "Award supports DIU's Project FORGE to accelerate production of a critical munitions program through advanced additive manufacturing FREMONT, Calif. , Dec. 22, 2025 /PRNewswire/ --\u00a0Velo3D, Inc. (NASDAQ: VELO), a leading additive manufacturing technology company for mission-critical metal parts has entered into an Other Transition Agreement (OTA) contract with the U.S. Department of War's (DoW) Defense Innovation Unit (DIU) in support of a major weapon system program of record.", "url": "https://www.prnewswire.com/news-releases/velo3d-secures-department-of-war-contract-valued-at-32-6m-to-eliminate-critical-defense-manufacturing-bottleneck-302647770.html"}, {"symbol": "VELO", "publishedDate": "2025-12-22 01:00:00", "publisher": "Business Wire", "title": "FDA Approves Genentech's Lunsumio VELO\u2122 for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma", "image": "https://images.financialmodelingprep.com/news/fda-approves-genentechs-lunsumio-velo-for-subcutaneous-use-in-20251222.jpg", "site": "businesswire.com", "text": "SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved CD20xCD3 bispecific Lunsumio VELO\u2122 (mosunetuzumab-axgb), as a subcutaneous (SC) formulation, for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of systemic therapy, based on results from the Phase I/II GO29781 study. Based on the study re.", "url": "https://www.businesswire.com/news/home/20251221794897/en/FDA-Approves-Genentech%E2%80%99s-Lunsumio-VELO%E2%84%A2-for-Subcutaneous-Use-in-Relapsed-or-Refractory-Follicular-Lymphoma/"}, {"symbol": "QNCX", "publishedDate": "2025-12-18 01:58:49", "publisher": "Defense World", "title": "Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives Consensus Recommendation of \u201cModerate Buy\u201d from Analysts", "image": "https://images.financialmodelingprep.com/news/quince-therapeutics-inc-nasdaqqncx-receives-consensus-recommendation-of-moderate-buy-20251218.png", "site": "defenseworld.net", "text": "Quince Therapeutics, Inc. (NASDAQ: QNCX - Get Free Report) has received an average recommendation of \"Moderate Buy\" from the seven research firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, four have issued a buy recommendation and one", "url": "https://www.defenseworld.net/2025/12/18/quince-therapeutics-inc-nasdaqqncx-receives-consensus-recommendation-of-moderate-buy-from-analysts.html"}, {"symbol": "DTSS", "publishedDate": "2025-12-17 09:30:00", "publisher": "PRNewsWire", "title": "Datasea Advances Deployment of an Acoustics + AI-Driven Next-Generation Beauty & Health Intelligence System, Addressing a Multi-Billion-Dollar China Market Opportunity", "image": "https://images.financialmodelingprep.com/news/datasea-advances-deployment-of-an-acoustics-aidriven-nextgeneration-beauty-20251217.jpg", "site": "prnewswire.com", "text": "BEIJING , Dec. 17, 2025 /PRNewswire/ -- Datasea (Beijing) Technology Co., Ltd. (\"Datasea\"), a subsidiary of Datasea Inc. (NASDAQ: DTSS), today announced a strategic partnership with Shenzhen Yizhimei Technology Co., Ltd.", "url": "https://www.prnewswire.com/news-releases/datasea-advances-deployment-of-an-acoustics--aidriven-next-generation-beauty--health-intelligence-system-addressing-a-multi-billion-dollar-china-market-opportunity-302644758.html"}, {"symbol": "QNCX", "publishedDate": "2025-12-15 08:00:00", "publisher": "Business Wire", "title": "Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia", "image": "https://images.financialmodelingprep.com/news/quince-therapeutics-announces-last-patient-last-visit-in-phase-20251215.jpg", "site": "businesswire.com", "text": "SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that the last patient has completed their last visit in the company's pivotal Phase 3 NEAT (Neurological Effects of eDSP in Subjects with A-T; NCT06193200/IEDAT-04-2022) clinical trial of its lead asset, encapsulated dexamethasone sodium phosphate (eDSP), in patie.", "url": "https://www.businesswire.com/news/home/20251215328276/en/Quince-Therapeutics-Announces-Last-Patient-Last-Visit-in-Phase-3-NEAT-Clinical-Trial-in-Patients-with-Ataxia-Telangiectasia/"}, {"symbol": "DTSS", "publishedDate": "2025-12-11 09:30:00", "publisher": "PRNewsWire", "title": "Datasea Announces Breakthrough in Acoustic-Driven Brain-Computer Interface Technology", "image": "https://images.financialmodelingprep.com/news/datasea-announces-breakthrough-in-acousticdriven-braincomputer-interface-technology-20251211.jpg", "site": "prnewswire.com", "text": "Developing Healthcare and Intelligent Interaction Through Core Acoustic Innovation BEIJING , Dec. 11, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) (\"Datasea\" or the \"Company\"), a global technology enterprise specializing in acoustic high-tech innovations and AI multimodal digital solutions, today announced progress in its research and development efforts related to brain\u2013computer interfaces (BCI) technologies. The Company's Real-Time Closed-Loop Vibration-Enhanced BCI System and Acoustic-Coupled EEG Signal Enhancement System have successfully completed engineering-stage development.", "url": "https://www.prnewswire.com/news-releases/datasea-announces-breakthrough-in-acoustic-driven-braincomputer-interface-technology-302638934.html"}, {"symbol": "SDOT", "publishedDate": "2025-12-11 02:26:54", "publisher": "Defense World", "title": "Sadot Group (NASDAQ:SDOT) Stock Price Up 0.3%  \u2013 What\u2019s Next?", "image": "https://images.financialmodelingprep.com/news/sadot-group-nasdaqsdot-stock-price-up-03-whats-next-20251211.png", "site": "defenseworld.net", "text": "Sadot Group Inc. (NASDAQ: SDOT - Get Free Report)'s stock price was up 0.3% during trading on Wednesday. The company traded as high as $3.05 and last traded at $2.99. Approximately 18,404 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 51,234 shares. The stock had previously closed", "url": "https://www.defenseworld.net/2025/12/11/sadot-group-nasdaqsdot-stock-price-up-0-3-whats-next.html"}, {"symbol": "QNCX", "publishedDate": "2025-12-10 16:05:00", "publisher": "Business Wire", "title": "Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders", "image": "https://images.financialmodelingprep.com/news/quince-therapeutics-announces-publication-of-use-of-edsp-in-20251210.jpg", "site": "businesswire.com", "text": "SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, announced the publication of a summary of early-stage clinical studies of its Phase 3 lead asset, eDSP (dexamethasone sodium phosphate [DSP] encapsulated in a patient's own red blood cells), in pulmonary and inflammatory bowel disorders (IBD) in the scientific journal Frontiers i.", "url": "https://www.businesswire.com/news/home/20251210188416/en/Quince-Therapeutics-Announces-Publication-of-Use-of-eDSP-in-Early-Stage-Clinical-Studies-in-Pulmonary-and-Inflammatory-Bowel-Disorders/"}, {"symbol": "VELO", "publishedDate": "2025-12-10 03:56:27", "publisher": "Benzinga", "title": "Velo3D Shares Jump Over 16% In After-Hours Trading: Here's Why", "image": "https://images.financialmodelingprep.com/news/velo3d-shares-jump-over-16-in-afterhours-trading-heres-20251210.jpeg", "site": "feeds.benzinga.com", "text": "Velo3D shares jumped in after-hours trading after Mears Machine Corporation delivered a complete aerospace hardware set using its Sapphire XC additive manufacturing system.", "url": "https://www.benzinga.com/markets/equities/25/12/49297942/velo3d-shares-jump-over-16-in-after-hours-trading-heres-why"}, {"symbol": "VELO", "publishedDate": "2025-12-08 12:29:11", "publisher": "Seeking Alpha", "title": "Velo3D: Turnaround From Volatile Hardware To Recurring Services", "image": "https://images.financialmodelingprep.com/news/velo3d-turnaround-from-volatile-hardware-to-recurring-services-20251208.jpg", "site": "seekingalpha.com", "text": "Velo3D is a high-risk turnaround play, shifting from hardware sales to a recurring, service-driven RPS model targeting mission-critical 3D printing markets. Management guides for 50% sales CAGR through 2027, EBITDA breakeven by mid-2026, and Q4 2025 gross margin above 30%, contingent on RPS scaling. Recent bookings surged 200% YoY, supporting a potential turnaround, but customer concentration and capital constraints present material risks.", "url": "https://seekingalpha.com/article/4851222-velo3d-turnaround-from-volatile-hardware-to-recurring-services"}, {"symbol": "SOWG", "publishedDate": "2025-12-01 01:28:52", "publisher": "Defense World", "title": "Sow Good (OTCMKTS:SOWG) and Saputo (OTCMKTS:SAPIF) Critical Analysis", "image": "https://images.financialmodelingprep.com/news/sow-good-otcmktssowg-and-saputo-otcmktssapif-critical-analysis-20251201.png", "site": "defenseworld.net", "text": "Sow Good (OTCMKTS:SOWG - Get Free Report) and Saputo (OTCMKTS:SAPIF - Get Free Report) are both consumer defensive companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Institutional and Insider Ownership 10.7% of Sow Good", "url": "https://www.defenseworld.net/2025/12/01/sow-good-otcmktssowg-and-saputo-otcmktssapif-critical-analysis.html"}, {"symbol": "LIPO", "publishedDate": "2025-11-26 02:45:00", "publisher": "Defense World", "title": "Lipella Pharmaceuticals (NASDAQ:LIPO) Trading Down 14.8%  \u2013 Here\u2019s What Happened", "image": "https://images.financialmodelingprep.com/news/lipella-pharmaceuticals-nasdaqlipo-trading-down-148-heres-what-happened-20251126.jpg", "site": "defenseworld.net", "text": "Lipella Pharmaceuticals Inc. (NASDAQ: LIPO - Get Free Report)'s stock price dropped 14.8% on Tuesday. The stock traded as low as $0.3410 and last traded at $0.3410. Approximately 22,645 shares traded hands during trading, a decline of 96% from the average daily volume of 631,420 shares. The stock had previously closed at $0.40. Lipella Pharmaceuticals", "url": "https://www.defenseworld.net/2025/11/26/lipella-pharmaceuticals-nasdaqlipo-trading-down-14-8-heres-what-happened.html"}, {"symbol": "QNCX", "publishedDate": "2025-11-24 08:00:00", "publisher": "Business Wire", "title": "Quince Therapeutics to Participate at Investor Events in December 2025", "image": "https://images.financialmodelingprep.com/news/quince-therapeutics-to-participate-at-investor-events-in-december-20251124.jpg", "site": "businesswire.com", "text": "SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that senior management will participate at three investor events in December 2025: Dirk Thye, M.D., Quince's Chief Executive Officer and Chief Medical Officer, will participate at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025,.", "url": "https://www.businesswire.com/news/home/20251124942104/en/Quince-Therapeutics-to-Participate-at-Investor-Events-in-December-2025/"}, {"symbol": "SDOT", "publishedDate": "2025-11-19 17:00:00", "publisher": "Accesswire", "title": "Sadot Group, Inc. Reports Third Quarter 2025 Results", "image": "https://images.financialmodelingprep.com/news/sadot-group-inc-reports-third-quarter-2025-results-20251119.jpg", "site": "accessnewswire.com", "text": "BURLESON, TX / ACCESS Newswire / November 19, 2025 / Sadot Group Inc. (Nasdaq:SDOT) (\"Sadot Group\", \"Sadot\" or the \"Company\"), today announced its financial results for the third quarter ended September 30, 2025. The quarterly financial statements for the three and nine months ended September 30, 2025, are available on the \"investors\" section of the Company's website (www.sadotgroupinc.com/sec-filings) and can also be found on www.sec.gov.", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/sadot-group-inc.-reports-third-quarter-2025-results-1104734"}, {"symbol": "DTSS", "publishedDate": "2025-11-18 09:30:00", "publisher": "PRNewsWire", "title": "Datasea Inc. Issues Statement Regarding Recent Market Activity", "image": "https://images.financialmodelingprep.com/news/datasea-inc-issues-statement-regarding-recent-market-activity-20251118.jpg", "site": "prnewswire.com", "text": "BEIJING , Nov. 18, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) (\"Datasea\" or the \"Company\") ,a Nevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today issues a brief statement regarding recent trading activity in its common stock. The Company has observed fluctuations in its share price and trading volume over the past several days.", "url": "https://www.prnewswire.com/news-releases/datasea-inc-issues-statement-regarding-recent-market-activity-302618637.html"}, {"symbol": "DTSS", "publishedDate": "2025-11-17 03:33:12", "publisher": "Defense World", "title": "Datasea (NASDAQ:DTSS) and Stem (NYSE:STEM) Head to Head Contrast", "image": "https://images.financialmodelingprep.com/news/datasea-nasdaqdtss-and-stem-nysestem-head-to-head-contrast-20251117.jpg", "site": "defenseworld.net", "text": "Datasea (NASDAQ: DTSS - Get Free Report) and Stem (NYSE: STEM - Get Free Report) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk. Institutional and Insider Ownership 82.1% of Datasea", "url": "https://www.defenseworld.net/2025/11/17/datasea-nasdaqdtss-and-stem-nysestem-head-to-head-contrast.html"}, {"symbol": "SOWG", "publishedDate": "2025-11-14 12:01:35", "publisher": "Seeking Alpha", "title": "Sow Good Inc. (SOWG) Q3 2025 Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/sow-good-inc-sowg-q3-2025-earnings-call-transcript-20251114.jpg", "site": "seekingalpha.com", "text": "Sow Good Inc. ( SOWG ) Q3 2025 Earnings Call November 14, 2025 10:00 AM EST Company Participants Claudia Goldfarb - Co-Founder, CEO & Director Donna Guy - Chief Financial Officer Conference Call Participants Cody Slach - Gateway Group, Inc. Peter Sidoti - Sidoti & Company, Inc. Presentation Operator Good morning, everyone, and thank you for participating in today's conference call to discuss Sow Good's financial results for the third quarter ended September 30, 2025. Joining us today are Sow Good's Co-Founder and CEO, Claudia Goldfarb; and Chief Financial Officer, Donna Guy.", "url": "https://seekingalpha.com/article/4843925-sow-good-inc-sowg-q3-2025-earnings-call-transcript"}, {"symbol": "SOWG", "publishedDate": "2025-11-14 08:00:00", "publisher": "GlobeNewsWire", "title": "Sow Good Reports Third Quarter 2025 Results", "image": "https://images.financialmodelingprep.com/news/sow-good-reports-third-quarter-2025-results-20251114.jpg", "site": "globenewswire.com", "text": "DALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Sow Good Inc. (Nasdaq: SOWG) (\u201cSow Good\u201d or \u201cthe Company\u201d), a leading freeze-dried food and candy manufacturer, is reporting financial and operating results for the third quarter ended September 30, 2025.", "url": "https://www.globenewswire.com/news-release/2025/11/14/3188264/0/en/Sow-Good-Reports-Third-Quarter-2025-Results.html"}, {"symbol": "DTSS", "publishedDate": "2025-11-13 09:31:00", "publisher": "PRNewsWire", "title": "Datasea Reports First Quarter Gross Profit of $1.2 Million, a 4.9x Increase Year-Over-Year in its Strategy to Achieve High-Tech Product Profitability", "image": "https://images.financialmodelingprep.com/news/datasea-reports-first-quarter-gross-profit-of-12-million-20251113.jpg", "site": "prnewswire.com", "text": "Gross Margin Rose to 8.5% through High-Tech Products Mix and Cost Efficiencies BEIJING , Nov. 13, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) (\"Datasea\" or the \"Company\"), a Nevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today announces its unaudited financial results for its first fiscal quarter ended September 30, 2025. Additional information will also be set forth in our Quarterly Report on Form 10-Q\u00a0for the quarter ended September 30, 2025.", "url": "https://www.prnewswire.com/news-releases/datasea-reports-first-quarter-gross-profit-of-1-2-million-a-4-9x-increase-year-over-year-in-its-strategy-to-achieve-high-tech-product-profitability-302614616.html"}, {"symbol": "QNCX", "publishedDate": "2025-11-12 16:05:00", "publisher": "Business Wire", "title": "Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results", "image": "https://images.financialmodelingprep.com/news/quince-therapeutics-provides-business-update-and-reports-third-quarter-20251112.jpg", "site": "businesswire.com", "text": "SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an update on the company's development pipeline and reported financial results for the third quarter ended September 30, 2025. Dirk Thye, M.D., Quince's Chief Executive Officer and Chief Medical Officer, said, \u201cQuince remains on track to report topline results for.", "url": "https://www.businesswire.com/news/home/20251112266523/en/Quince-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-2025-Financial-Results/"}, {"symbol": "VELO", "publishedDate": "2025-11-10 19:11:36", "publisher": "Seeking Alpha", "title": "Velo3D, Inc. (VLDXD) Q3 2025 Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/velo3d-inc-vldxd-q3-2025-earnings-call-transcript-20251110.jpg", "site": "seekingalpha.com", "text": "Velo3D, Inc. (OTC:VLDXD) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Arun Jeldi - Chairman & CEO Hull Xu - CFO & Principal Financial Officer Conference Call Participants James Carbonara - Hayden Ir, LLC Jaeson Schmidt - Lake Street Capital Markets, LLC, Research Division Presentation Operator Greetings, and welcome to the Velo3D Third Quarter 2025 Financial Results. [Operator Instructions] Please note, this conference is being recorded.", "url": "https://seekingalpha.com/article/4841601-velo3d-inc-vldxd-q3-2025-earnings-call-transcript"}, {"symbol": "VELO", "publishedDate": "2025-11-10 16:05:00", "publisher": "PRNewsWire", "title": "Velo3D Now Listed on Nasdaq (Ticker: VELO) Announces Third Quarter 2025 Financial Results", "image": "https://images.financialmodelingprep.com/news/velo3d-now-listed-on-nasdaq-ticker-velo-announces-third-quarter-20251110.jpg", "site": "prnewswire.com", "text": "Revenue of $13.6 million Backlog of $21.1 million as of September 30, 2025\u00a0 Reaffirms expectation for 2025 revenue between $50 and $60 million Reaffirms expectation to be EBITDA positive in the first half of 2026 FREMONT, Calif. , Nov. 10, 2025 /PRNewswire/ --\u00a0Velo3D, Inc. (Nasdaq: VELO) (\"Velo3D or the \"Company\"), a leader in additive manufacturing (\"AM\") technology known for transforming aerospace and defense supply chains through world-class metal AM, today announced financial results for its third quarter ended September 30, 2025.", "url": "https://www.prnewswire.com/news-releases/velo3d-now-listed-on-nasdaq-ticker-velo-announces-third-quarter-2025-financial-results-302610599.html"}, {"symbol": "QNCX", "publishedDate": "2025-11-10 16:05:00", "publisher": "Business Wire", "title": "Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia", "image": "https://images.financialmodelingprep.com/news/quince-therapeutics-announces-positive-idsmb-review-for-edsp-in-20251110.jpg", "site": "businesswire.com", "text": "SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the positive outcome of its pre-planned safety analysis conducted by an independent data and safety monitoring board (iDSMB) for the company's ongoing pivotal Phase 3 NEAT (Neurological Effects of eDSP in Subjects with A-T; NCT06193200/IEDAT-04-2022) clinical tria.", "url": "https://www.businesswire.com/news/home/20251021956399/en/Quince-Therapeutics-Announces-Positive-iDSMB-Review-for-eDSP-in-Pivotal-Phase-3-NEAT-Clinical-Trial-in-Ataxia-Telangiectasia/"}, {"symbol": "RPID", "publishedDate": "2025-11-07 17:06:14", "publisher": "Seeking Alpha", "title": "Rapid Micro Biosystems, Inc. (RPID) Q3 2025 Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/rapid-micro-biosystems-inc-rpid-q3-2025-earnings-call-20251107.jpg", "site": "seekingalpha.com", "text": "Rapid Micro Biosystems, Inc. ( RPID ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Michael Beaulieu - Vice President of Investor Relations & Corporate Communications Robert Spignesi - CEO, President & Director Sean Wirtjes - Chief Financial Officer Conference Call Participants Thomas Flaten - Lake Street Capital Markets, LLC, Research Division Paul Knight - KeyBanc Capital Markets Inc., Research Division Brendan Smith - TD Cowen, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Rapid Micro Biosystems Third Quarter 2025 Earnings Conference Call.", "url": "https://seekingalpha.com/article/4840632-rapid-micro-biosystems-inc-rpid-q3-2025-earnings-call-transcript"}, {"symbol": "RPID", "publishedDate": "2025-11-07 08:16:07", "publisher": "Zacks Investment Research", "title": "Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Misses Revenue Estimates", "image": "https://images.financialmodelingprep.com/news/rapid-micro-biosystems-inc-rpid-reports-q3-loss-misses-20251107.jpg", "site": "zacks.com", "text": "Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.26 per share a year ago.", "url": "https://www.zacks.com/stock/news/2787541/rapid-micro-biosystems-inc-rpid-reports-q3-loss-misses-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2787541"}, {"symbol": "RPID", "publishedDate": "2025-11-07 06:00:00", "publisher": "GlobeNewsWire", "title": "Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance", "image": "https://images.financialmodelingprep.com/news/rapid-micro-biosystems-reports-third-quarter-2025-financial-results-20251107.jpg", "site": "globenewswire.com", "text": "LEXINGTON, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the \u201cCompany\u201d), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the third quarter ended September 30, 2025.", "url": "https://www.globenewswire.com/news-release/2025/11/07/3183485/33206/en/Rapid-Micro-Biosystems-Reports-Third-Quarter-2025-Financial-Results-Announces-Record-Multi-System-Customer-Order-and-Raises-Full-Year-Revenue-and-System-Placement-Guidance.html"}, {"symbol": "SMCX", "publishedDate": "2025-11-04 12:52:30", "publisher": "ETF Trends", "title": "Top Performing Leveraged/Inverse ETFs: 11/02/2025", "image": "https://images.financialmodelingprep.com/news/top-performing-leveragedinverse-etfs-11022025-20251104.jpg", "site": "etftrends.com", "text": "Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.", "url": "https://www.etftrends.com/leveraged-inverse-content-hub/top-performing-leveraged-inverse-etfs-11-02-2025/"}, {"symbol": "LIPO", "publishedDate": "2025-11-04 02:50:57", "publisher": "Defense World", "title": "Lipella Pharmaceuticals (NASDAQ:LIPO) Stock Price Up 4.2%  \u2013 Still a Buy?", "image": "https://images.financialmodelingprep.com/news/lipella-pharmaceuticals-nasdaqlipo-stock-price-up-42-still-a-buy-20251104.jpg", "site": "defenseworld.net", "text": "Lipella Pharmaceuticals Inc. (NASDAQ: LIPO - Get Free Report) shares rose 4.2% on Monday. The stock traded as high as $0.4532 and last traded at $0.4532. Approximately 5,172 shares changed hands during trading, a decline of 99% from the average daily volume of 671,835 shares. The stock had previously closed at $0.4350. Lipella Pharmaceuticals Price", "url": "https://www.defenseworld.net/2025/11/04/lipella-pharmaceuticals-nasdaqlipo-stock-price-up-4-2-still-a-buy.html"}, {"symbol": "VELO", "publishedDate": "2025-10-31 09:00:00", "publisher": "PRNewsWire", "title": "Velo3D to Announce Third Quarter 2025 Results on November 10, 2025", "image": "https://images.financialmodelingprep.com/news/velo3d-to-announce-third-quarter-2025-results-on-november-20251031.jpg", "site": "prnewswire.com", "text": "FREMONT, Calif. , Oct. 31, 2025 /PRNewswire/ -- Velo3D, Inc. (Nasdaq: VELO), a leading provider of advanced metal additive manufacturing (AM) technology transforming aerospace and defense supply chains, today announced that it will release its third quarter 2025 financial results after the market close on November 10, 2025.", "url": "https://www.prnewswire.com/news-releases/velo3d-to-announce-third-quarter-2025-results-on-november-10-2025-302600830.html"}, {"symbol": "SOWG", "publishedDate": "2025-10-31 08:00:00", "publisher": "GlobeNewsWire", "title": "Sow Good to Hold Third Quarter 2025 Conference Call on Friday, November 14, 2025 at 10:00 a.m. ET", "image": "https://images.financialmodelingprep.com/news/sow-good-to-hold-third-quarter-2025-conference-call-20251031.jpg", "site": "globenewswire.com", "text": "IRVING, Texas, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Sow Good Inc. (Nasdaq: SOWG) (\u201cSow Good\u201d or \u201cthe Company\u201d), a trailblazer in the freeze dried candy and treat industry, will hold a conference call on Friday, November 14, 2025, at 10:00 a.m. Eastern time to discuss its results for the third quarter ended September 30, 2025. The Company will provide its financial results in a press release prior to the conference call.", "url": "https://www.globenewswire.com/news-release/2025/10/31/3178271/0/en/Sow-Good-to-Hold-Third-Quarter-2025-Conference-Call-on-Friday-November-14-2025-at-10-00-a-m-ET.html"}, {"symbol": "RPID", "publishedDate": "2025-10-31 01:33:07", "publisher": "Defense World", "title": "Rapid Micro Biosystems (RPID) to Release Earnings on Friday", "image": "https://images.financialmodelingprep.com/news/rapid-micro-biosystems-rpid-to-release-earnings-on-friday-20251031.png", "site": "defenseworld.net", "text": "Rapid Micro Biosystems (NASDAQ: RPID - Get Free Report) is expected to release its Q3 2025 results before the market opens on Friday, November 7th. Analysts expect Rapid Micro Biosystems to post earnings of ($0.26) per share and revenue of $7.60 million for the quarter. Rapid Micro Biosystems has set its FY 2025 guidance at EPS.Interested", "url": "https://www.defenseworld.net/2025/10/31/rapid-micro-biosystems-rpid-to-release-earnings-on-friday.html"}, {"symbol": "RPID", "publishedDate": "2025-10-30 16:45:00", "publisher": "GlobeNewsWire", "title": "Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/rapid-micro-biosystems-to-participate-in-the-stifel-2025-20251030.jpg", "site": "globenewswire.com", "text": "LEXINGTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the \u201cCompany\u201d), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Stifel 2025 Healthcare Conference in New York, NY.", "url": "https://www.globenewswire.com/news-release/2025/10/30/3177993/33206/en/Rapid-Micro-Biosystems-to-Participate-in-the-Stifel-2025-Healthcare-Conference.html"}, {"symbol": "RPID", "publishedDate": "2025-10-28 17:05:00", "publisher": "GlobeNewsWire", "title": "Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025", "image": "https://images.financialmodelingprep.com/news/rapid-micro-biosystems-to-announce-third-quarter-2025-financial-20251028.jpg", "site": "globenewswire.com", "text": "LEXINGTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the \u201cCompany\u201d), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2025 financial results prior to the market open on Friday, November 7, 2025.", "url": "https://www.globenewswire.com/news-release/2025/10/28/3176019/33206/en/Rapid-Micro-Biosystems-to-Announce-Third-Quarter-2025-Financial-Results-on-November-7-2025.html"}, {"symbol": "VELO", "publishedDate": "2025-10-27 09:00:00", "publisher": "PRNewsWire", "title": "Velo3D to Present at Starting 5 Virtual Investor Conference: Defense Edition, Hosted by MS Microcaps & Atrium Research, on October 27 at 1:25 p.m. ET", "image": "https://images.financialmodelingprep.com/news/velo3d-to-present-at-starting-5-virtual-investor-conference-20251027.jpg", "site": "prnewswire.com", "text": "FREMONT, Calif. , Oct. 27, 2025 /PRNewswire/ --\u00a0Velo3D, Inc.\u00a0(Nasdaq: VELO), a leading provider of advanced metal additive manufacturing (AM) technology transforming aerospace and defense supply chains, today announced that company management will present at the Starting 5 Virtual Investor Conference: Defense Edition, hosted by MS Microcaps and Atrium Research, on October 27, 2025, at 1:25 p.m.", "url": "https://www.prnewswire.com/news-releases/velo3d-to-present-at-starting-5-virtual-investor-conference-defense-edition-hosted-by-ms-microcaps--atrium-research-on-october-27-at-125-pm-et-302594518.html"}]